Smart Diabetes Management Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)
Market Report I 2025-06-20 I 400 Pages I EMR Inc.
The smart diabetes management market was valued at USD 6.04 Billion in 2024, driven by the rising prevalence of diabetes and the advancements in diabetes management technology across the 8 major markets. It is expected to grow at a CAGR of 14.80% during the forecast period of 2025-2034, with the values likely to reach USD 24.01 Billion by 2034.
Smart Diabetes Management Market Overview
Smart diabetes management leverages technology to help diabetes patients manage their condition and improve the quality of their lives. The market is driven by the rising prevalence of diabetes and a growing trend towards self-diabetes management. The rising innovation and diversification in diabetes care products are expected to favor market growth in the coming years. Moreover, the increasing demand for smart glucose level monitoring and insulin devices, which are integrated with digital health solutions, is poised to catalyze market expansion in the forecast period.
Smart Diabetes Management Market Growth Drivers
Increasing Prevalence of Diabetes Drives Market Growth
Recent data suggests that more than half a billion people in the world are suffering from diabetes. The global prevalence of the disease is reported to be 6.1%, with diabetes ranking as one of the top 10 leading causes of disability and death. Further, it is projected that the number of people with diabetes is likely to more than double (1.3 billion) in the next 30 years, reflecting the need for smart diabetes management tools like continuous glucose monitors (CGMs), smart insulin pumps, and smart insulin pens for improved control of the condition. Thus, the rising burden of diabetes is expected to fuel the market growth.
Smart Diabetes Management Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Rise in Regulatory Approvals to Affect the Market Landscape Significantly
In August 2024, the Food and Drug Administration (FDA) approved the Simplera continuous glucose monitor (CGM), a disposable, easy-to-use, all-in-one CGM developed by Medtronic. The Simplera platform features a discreet and simplified design and includes Simplera CGM and Simplera Sync Sensor. The rise in such regulatory approvals of innovative devices is projected to support market growth.
Launch of Innovative Products Poised to Augment Smart Diabetes Management Market Demand
In February 2024, Kakao Healthcare, a major provider of virtual healthcare services and digital transformation solutions for hospitals, introduced an AI-powered mobile diabetes management app called PASTA (Personalised, Accessible, Supportive, Tech-enabled, and Affordable). The mHealth app is designed to link with two CGM devices: Dexcom's G7 and i-SENS, Inc.'s CareSens Air. By the second quarter, the app is also expected to pair with the Mallya smart cap for insulin pens. The surge in the launch of such advanced diabetes management apps is poised to augment the market demand in the coming years.
Growing Patient Awareness to Elevate the Smart Diabetes Management Market Value
A significant market trend is the growing awareness about the benefits of smart diabetes management devices as a result of public health initiatives and awareness campaigns. This is prompting diabetes patients to use more advanced diabetes management tools such as real-time glucose monitoring systems to efficiently track their condition.
Increasing Aging Population to Boost Smart Diabetes Management Market Size
The aging population is another key driver of the market, boosting the demand for smart diabetes management tools that allow for easy monitoring and medication adjustments for this age group. Devices that feature simplified interfaces such as easy-to-read displays and voice-activated systems are gaining popularity among elderly patients, which is set to influence the market landscape in the forecast period.
Smart Diabetes Management Market Segmentation
Market Breakup by Devices
- Continuous Glucose Monitoring Systems
- Smart Insulin Pens
- Smart Insulin Pumps
- Smart Glucose Meters
- Closed Loop Systems
Market Breakup by Device Type
- Handheld
- Wearable
Market Breakup by Application
- Type 1 Diabetes
- Type 2 Diabetes
Market Breakup by End User
- Hospitals
- Specialty Clinics
- Home Healthcare
- Others
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Independent Pharmacies
- Online Pharmacies
- Others
Market Breakup by Region
- United States
- EU-4 and the United Kingdom
??- Germany
??- France
??- Italy
??- Spain
- Japan
- India
Smart Diabetes Management Market Share
The Devices Segment is Projected to Hold Substantial Market Share
Based on the devices, the market is segmented into continuous glucose monitoring systems, smart insulin pens, smart insulin pumps, smart glucose meters, and closed-loop systems. The continuous glucose monitoring (CGM) segment holds a high market value due to its ability to track glucose levels over time and provide real-time data on fluctuations in glucose levels. On the other hand, smart insulin pens like NovoPen 6 and NovoPen Echo Plus help in automatically tracking and recording insulin dosing information with each injection.
Smart Diabetes Management Market Analysis by Region
The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States leads the market share which can be attributed to the strong presence of key players boasting a diversified product portfolio and the high demand for technologically advanced treatments to manage diabetes. The market in the region is also influenced by the growing trend towards the self-management of the disease and the preference for personalized diabetes management solutions.
Leading Players in the Smart Diabetes Management Market
The key features of the market report comprise patent analysis, clinical trial analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Medtronic plc
This American-Irish medical device company is one of the leading players in the market, known for manufacturing and marketing diagnostic and therapeutic medical products. One of the key products of the company is Guardian Connect, a smart continuous glucose monitoring (CGM) system, that can alert diabetes patients 60 minutes in advance in response to high or low blood glucose levels.
Abbott Laboratories
Abbott Laboratories, headquartered in Illinois, United States, contributes significantly towards the advancement of diabetes care. Abbott's FreeStyle Libre continuous glucose monitoring system is a popular product that is indicated for measuring interstitial fluid glucose levels in individuals with diabetes mellitus who are 4 years of age or above.
Dexcom, Inc.
Dexcom, headquartered in California, United States, is a leading company that manufactures and distributes continuous glucose monitoring systems for diabetes management. The company boasts manufacturing facilities in Arizona, Batu Kawan (Malaysia), and Mesa.
Roche Diabetes Care
Roche Diabetes Care, a global leader in diabetes management and services, specializes in the development of blood glucose monitoring systems. Its Accu-Check brand offers innovative solutions for diabetes patients including data management systems, blood glucose meters, and education programs.
Other key players in the market include Insulet Corporation, Tandem Diabetes Care, Inc., Eli Lilly and Company, Novo Nordisk A/S, Ascensia Diabetes Care Holdings AG, and Johnson & Johnson (LifeScan, Inc.).
Key Questions Answered in the Smart Diabetes Management Market Report
- What was the smart diabetes management market value in 2024?
- What is the smart diabetes management market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on devices?
- What is the market breakup based on device type?
- What is the market breakup by application?
- Who are the major end users in the market?
- What are the major factors aiding the smart diabetes management market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- How do the prevalence and incidence of diabetes affect the market landscape?
- What are the major smart diabetes management market trends?
- How does the emergence of mobile health applications impact the market size?
- Which devices will dominate the market share?
- Which device type is expected to have a high market value in the coming years?
- Which application will experience the highest demand in the market segment?
- Which end user is projected to contribute to the highest market growth?
- Who are the key players involved in the smart diabetes management market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Smart Diabetes Management Market Overview
3.1 Global Smart Diabetes Management Market Historical Value (2018-2024)
3.2 Global Smart Diabetes Management Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Smart Diabetes Management Market Landscape
5.1 Global Smart Diabetes Management Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Smart Diabetes Management Market: Product Landscape
5.2.1 Analysis by Device Type
5.2.2 Analysis by Modality
5.2.3 Analysis by Application
6 Global Smart Diabetes Management Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter's Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Smart Diabetes Management Market Segmentation (218-2034)
7.1 Global Smart Diabetes Management Market (2018-2034) by Device Type
7.1.1 Market Overview
7.1.2 Continuous Glucose monitoring Systems
7.1.3 Smart Insulin Pens
7.1.4 Smart Insulin Pumps
7.1.5 Smart Glucose Meters
7.1.6 Closed Loop Systems
7.2 Global Smart Diabetes Management Market (2018-2034) by Modality
7.2.1 Market Overview
7.2.2 Handheld
7.2.3 Wearable
7.3 Global Smart Diabetes Management Market (2018-2034) by Application
7.3.1 Market Overview
7.3.2 Type 1 Diabetes
7.3.3 Type 2 Diabetes
7.4 Global Smart Diabetes Management Market (2018-2034) by End User
7.4.1 Market Overview
7.4.2 Hospitals & Clinics
7.4.3 Homecare Settings
7.4.4 Others
7.5 Global Smart Diabetes Management Market (2018-2034) by Distribution Channel
7.5.1 Market Overview
7.5.2 Hospital Pharmacies
7.5.3 Independent Pharmacies
7.5.4 Online Pharmacies
7.5.5 Others
7.6 Global Smart Diabetes Management Market (2018-2034) by Region
7.6.1 Market Overview
7.6.2 North America
7.6.3 Europe
7.6.4 Asia Pacific
7.6.5 Latin America
7.6.6 Middle East and Africa
8 North America Smart Diabetes Management Market (218-2034)
8.1 North America Smart Diabetes Management Market (2018-2034) by Device Type
8.1.1 Market Overview
8.1.2 Continuous Glucose monitoring Systems
8.1.3 Smart Insulin Pens
8.1.4 Smart Insulin Pumps
8.1.5 Smart Glucose Meters
8.1.6 Closed Loop Systems
8.2 North America Smart Diabetes Management Market (2018-2034) by Modality
8.2.1 Market Overview
8.2.2 Handheld
8.2.3 Wearable
8.3 Global Smart Diabetes Management Market (2018-2034) by Application
8.3.1 Market Overview
8.3.2 Type 1 Diabetes
8.3.3 Type 2 Diabetes
8.4 North America Smart Diabetes Management Market (2018-2034) by End User
8.4.1 Market Overview
8.4.2 Hospitals & Clinics
8.4.3 Homecare Settings
8.4.4 Others
8.5 North America Smart Diabetes Management Market (2018-2034) by Distribution Channel
8.5.1 Market Overview
8.5.2 Hospital Pharmacies
8.5.3 Independent Pharmacies
8.5.4 Online Pharmacies
8.5.5 Others
8.6 North America Smart Diabetes Management Market (2018-2034) by Country
8.6.1 United States of America
8.6.2 Canada
9 Europe Smart Diabetes Management Market (218-2034)
9.1 Europe Smart Diabetes Management Market (2018-2034) by Device Type
9.1.1 Market Overview
9.1.2 Continuous Glucose monitoring Systems
9.1.3 Smart Insulin Pens
9.1.4 Smart Insulin Pumps
9.1.5 Smart Glucose Meters
9.1.6 Closed Loop Systems
9.2 Europe Smart Diabetes Management Market (2018-2034) by Modality
9.2.1 Market Overview
9.2.2 Handheld
9.2.3 Wearable
9.3 Europe Smart Diabetes Management Market (2018-2034) by Application
9.3.1 Market Overview
9.3.2 Type 1 Diabetes
9.3.3 Type 2 Diabetes
9.4 Europe Smart Diabetes Management Market (2018-2034) by End User
9.4.1 Market Overview
9.4.2 Hospitals & Clinics
9.4.3 Homecare Settings
9.4.4 Others
9.5 Europe Smart Diabetes Management Market (2018-2034) by Distribution Channel
9.5.1 Market Overview
9.5.2 Hospital Pharmacies
9.5.3 Independent Pharmacies
9.5.4 Online Pharmacies
9.5.5 Others
9.6 Europe Smart Diabetes Management Market (2018-2034) by Country
9.6.1 United Kingdom
9.6.2 Germany
9.6.3 France
9.6.4 Italy
9.6.5 Others
10 Asia Pacific Smart Diabetes Management Market (218-2034)
10.1 Asia Pacific Smart Diabetes Management Market (2018-2034) by Device Type
10.1.1 Market Overview
10.1.2 Continuous Glucose monitoring Systems
10.1.3 Smart Insulin Pens
10.1.4 Smart Insulin Pumps
10.1.5 Smart Glucose Meters
10.1.6 Closed Loop Systems
10.2 Asia Pacific Smart Diabetes Management Market (2018-2034) by Modality
10.2.1 Market Overview
10.2.2 Handheld
10.2.3 Wearable
10.3 Asia Pacific Smart Diabetes Management Market (2018-2034) by Application
10.3.1 Market Overview
10.3.2 Type 1 Diabetes
10.3.3 Type 2 Diabetes
10.4 Asia Pacific Smart Diabetes Management Market (2018-2034) by End User
10.4.1 Market Overview
10.4.2 Hospitals & Clinics
10.4.3 Homecare Settings
10.4.4 Others
10.5 Asia Pacific Smart Diabetes Management Market (2018-2034) by Distribution Channel
10.5.1 Market Overview
10.5.2 Hospital Pharmacies
10.5.3 Independent Pharmacies
10.5.4 Online Pharmacies
10.5.5 Others
10.6 Asia Pacific Smart Diabetes Management Market (2018-2034) by Country
10.6.1 China
10.6.2 Japan
10.6.3 India
10.6.4 ASEAN
10.6.5 Australia
10.6.6 Others
11 Latin America Smart Diabetes Management Market (218-2034)
11.1 Latin America Smart Diabetes Management Market (2018-2034) by Device Type
11.1.1 Market Overview
11.1.2 Continuous Glucose monitoring Systems
11.1.3 Smart Insulin Pens
11.1.4 Smart Insulin Pumps
11.1.5 Smart Glucose Meters
11.1.6 Closed Loop Systems
11.2 Latin America Smart Diabetes Management Market (2018-2034) by Modality
11.2.1 Market Overview
11.2.2 Handheld
11.2.3 Wearable
11.3 Latin America Smart Diabetes Management Market (2018-2034) by Application
11.3.1 Market Overview
11.3.2 Type 1 Diabetes
11.3.3 Type 2 Diabetes
11.4 Latin America Smart Diabetes Management Market (2018-2034) by End User
11.4.1 Market Overview
11.4.2 Hospitals & Clinics
11.4.3 Homecare Settings
11.4.4 Others
11.5 Latin America Smart Diabetes Management Market (2018-2034) by Distribution Channel
11.5.1 Market Overview
11.5.2 Hospital Pharmacies
11.5.3 Independent Pharmacies
11.5.4 Online Pharmacies
11.5.5 Others
11.6 Latin America Smart Diabetes Management Market (2018-2034) by Country
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Mexico
11.6.4 Others
12 Middle East and Africa Smart Diabetes Management Market (218-2034)
12.1 Middle East & Africa Smart Diabetes Management Market (2018-2034) by Device Type
12.1.1 Market Overview
12.1.2 Continuous Glucose monitoring Systems
12.1.3 Smart Insulin Pens
12.1.4 Smart Insulin Pumps
12.1.5 Smart Glucose Meters
12.1.6 Closed Loop Systems
12.2 Middle East and Africa Smart Diabetes Management Market (2018-2034) by Modality
12.2.1 Market Overview
12.2.2 Handheld
12.2.3 Wearable
12.3 Middle East and Africa Smart Diabetes Management Market (2018-2034) by Application
12.3.1 Market Overview
12.3.2 Type 1 Diabetes
12.3.3 Type 2 Diabetes
12.4 Middle East and Africa Smart Diabetes Management Market (2018-2034) by End User
12.4.1 Market Overview
12.4.2 Hospitals & Clinics
12.4.3 Homecare Settings
12.4.4 Others
12.5 Middle East and Africa Smart Diabetes Management Market (2018-2034) by Distribution Channel
12.5.1 Market Overview
12.5.2 Hospital Pharmacies
12.5.3 Independent Pharmacies
12.5.4 Online Pharmacies
12.5.5 Others
12.6 Middle East and Africa Smart Diabetes Management Market (2018-2034) by Country
12.6.1 Saudi Arabia
12.6.2 United Arab Emirates
12.6.3 Nigeria
12.6.4 South Africa
12.6.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
15 Grants Analysis
15.1 Analysis by Year
15.2 Analysis by Amount Awarded
15.3 Analysis by Issuing Authority
15.4 Analysis by Grant Application
15.5 Analysis by Funding Institute
15.6 Analysis by NIH Departments
15.7 Analysis by Recipient Organization
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Drug Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership and Collaborations
17.3 Analysis by Joint Ventures
17.4 Analysis by Leading Players
17.5 Analysis by Geography
17.6 Analysis by Merger & Acquisitions
18 Supplier Landscape
18.1 Market Share by Top 5 Companies
18.2 Medtronic plc
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News and Developments
18.2.5 Certifications
18.3 Abbott Laboratories
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News and Developments
18.3.5 Certifications
18.4 Dexcom, Inc.
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News and Developments
18.4.5 Certifications
18.5 Roche Diabetes Care
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News and Developments
18.5.5 Certifications
18.6 Insulet Corporation
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News and Developments
18.6.5 Certifications
18.7 Tandem Diabetes Care, Inc.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Company News and Developments
18.7.5 Certifications
18.8 Eli Lilly and Company
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Company News and Developments
18.8.5 Certifications
18.9 Novo Nordisk A/S
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Company News and Developments
18.9.5 Certifications
18.10 Ascensia Diabetes Care Holdings AG
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Company News and Developments
18.10.5 Certifications
18.11 Johnson & Johnson (LifeScan, Inc.)
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Company News and Developments
18.11.5 Certifications
19 Smart Diabetes Management Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.